Brief Reports
Copyright ©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Jun 14, 2005; 11(22): 3446-3450
Published online Jun 14, 2005. doi: 10.3748/wjg.v11.i22.3446
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 FasL expression on the surface of adenovirus infected SGC-7901 cells. A: Ad-LacZ (titer 4.0×105 CFU/mL); B: Ad-FasL (titer 2.8×105 CFU/mL).
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 FasL expression as examined by RT-PCR. A: SGC-7901-Fas-L (the FasL amplicon has a size of 231 bp); B: SGC-7901-vect (negative control); C: DNA marker.
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3 Treatment of SGC-7901 tumor-bearing mice with SGC-7901+FasL cells. A: Mice were injected with SGC-7901 cells (5×105), followed by treatment with FasL (n = 8); B: mice were injected with SGC-7901 cells (5×105); C: mice were injected with SGC-7901 cells (5×105), followed by treatment with PBS (n = 8). Tumor incidence is presented at each time point in Figure. P<0.0001.